Shine Receives Environmental Permit for Mo-99 Production facility

US-based Shine Medical Technologies has received the final supplemental environmental impact statement (EIS) from the US Nuclear Regulatory Commission (NRC) for a licence to operate a medical isotope production facility in Janesville, Wisconsin.

If approved, the 30-year operating licence will allow Shine to produce up to 8,200 six-day curies of molybdenum-99 (Mo-99) a week. Mo-99 is a precursor for technetium-99m extensively used in diagnostic medical imaging procedures.

To read more please visit:

Shine Receives Environmental Permit for Mo-99 Production facility

Source: Nuclear Engineering